Alpha-Mannosidosis in Cows

Alpha-mannosidosis is a rare inherited metabolic disease in cattle. It belongs to a group called lysosomal storage diseases, where the body cannot properly break down certain sugar-rich compounds inside cells. Those materials build up over time, especially in the brain and other tissues, and that buildup leads to progressive damage.

In cattle, this condition is most often discussed as a neurologic disease of calves and young cattle. Affected animals may look normal at birth or may be weak from the start. As the disease progresses, they can develop head tremors, poor balance, trouble rising, and worsening coordination. Some reports also describe aggression or exaggerated responses when the animal is disturbed.

This is not an infection and it is not contagious. It is a genetic condition passed through breeding. Because there is no proven curative treatment for cattle, the most important goals are confirming the diagnosis, protecting the calf's welfare, and making a herd plan with your vet to reduce future cases.

Alpha-mannosidosis is caused by an inherited deficiency of the enzyme alpha-mannosidase. Without enough of this enzyme, the calf cannot fully break down certain oligosaccharides inside lysosomes. Those compounds accumulate in cells and gradually damage the nervous system and other organs.

The inheritance pattern is autosomal recessive. That means a calf must inherit one abnormal copy of the gene from each parent to be affected. Cattle with only one abnormal copy are typically carriers. Carriers usually look normal, but if two carriers are bred together, each pregnancy has a risk of producing an affected calf.

Breed associations and veterinary references have documented alpha-mannosidosis in several cattle breeds, including Angus, Murray Grey, Simmental, Galloway, and Holstein. In practice, herd history and pedigree review can be very helpful, especially if there have been repeated neurologic calves, stillbirths, or unexplained losses in related animals.

Diagnosis starts with a full history and exam. Your vet will look at the calf's age, progression of signs, family history, and whether related animals have had similar problems. Because many calf neurologic diseases can look alike, your vet may first rule out more common causes such as infection, trauma, metabolic disease, or toxic exposure.

Confirming alpha-mannosidosis usually involves laboratory or genetic testing. Depending on the case, this may include DNA testing for known breed-associated mutations, specialized enzyme testing, or postmortem examination with histopathology. Tissue changes typical of a lysosomal storage disease can support the diagnosis, and genetic testing can help identify affected animals and carriers.

In herd situations, diagnosis often expands beyond the sick calf. Your vet may recommend testing close relatives, reviewing pedigrees, and working with the breed association or a veterinary diagnostic laboratory. That herd-level approach is often the most useful step for preventing future affected calves.

Prevention is centered on breeding management, not vaccines or feed changes. Because alpha-mannosidosis is inherited as an autosomal recessive trait, the key step is to avoid carrier-to-carrier matings. If your herd has a known case, your vet may recommend testing close relatives and reviewing pedigrees before future breeding decisions are made.

For seedstock and registered cattle, DNA testing is the most practical prevention tool. Breed organizations have published defect-testing pathways for alpha-mannosidosis in Angus-related cattle, and veterinary diagnostic laboratories may also offer testing for known mutations. A normal-looking animal can still be a carrier, so visual screening alone is not enough.

If an affected calf is born, keep good records. Document the sire, dam, related matings, and any stillbirths or neurologic calves in the family line. Then work with your vet to build a herd plan that matches your goals. In many herds, prevention means testing breeding animals, using only tested-free mates in at-risk lines, and removing high-risk pairings from the program.